Reliable and rapid antimicrobial resistance identification for appropriate therapy
10 Dec 2020

In this webinar, hear from Dr. Jose Alexander as he discusses the vital role a clinical microbiology lab can take in integrating rapid sample-to-result technology for the identification of antimicrobial resistance patterns.

Dr. Alexander, clinical microbiologist and director of microbiology, virology and immunology at AdventHealth Orlando, highlights how rapidly identifying resistance mechanisms is critical in directing appropriate and effective therapy to support positive patient outcomes and prevent further spread of antimicrobial resistance to help support local stewardship and infection control programs. Specifically, the webinar will address the threat posed by ESBL (extended-spectrum beta-lactamase) infections, which are resistant to a number of commonly used antibiotics, and the screening and reporting of ESBL on SPICE-M organisms.

Watch this webinar to learn about:

  • ESBL as a global threat
  • Unaccounted ESBL reservoirs
  • Rapid screening


Who should attend?
This webinar will provide insights for:

  • Clinical microbiologists
  • Microbiology laboratory staff
  • ID pharmacists
  • ID physicians


Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Thermo Fisher Scientific